Tag Archives: U.S.

Sanofi and Regeneron's Dupixent gets more positive feedback from U.S. FDA

FILE PHOTO: The logo of Sanofi is pictured during the Viva Tech start-up and technology summit in Paris, France, May 25, 2018. REUTERS/Charles Platiau/File Photo PARIS (Reuters) – The U.S. Food & Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies… Read More »

Novartis abandons effort for U.S. approval of biosimilar rituximab

FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo (Reuters) – Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory approval for a biosimilar of rituximab, a medication used… Read More »

Now THIS is fake health news – and it appears in major newspapers across the U.S.

October 11, 2018 Posted By Categories Gary Schwitzer is the founder and publisher of HealthNewsReview.org. He tweets as @garyschwitzer.  He usually avoids using the term “fake news” because shoddy, incomplete health care news is a much bigger problem.  But this is one example where the fake term applies. The story began:  “It is not often… Read More »